Skip to main content
Veterinary Medicines

Cepetor 1 mg/ml Solution for Injection for Dog and Cat

Authorised
  • Medetomidine hydrochloride

Product identification

Medicine name:
Cepetor 1 mg/ml Solution for Injection for Dog and Cat
CEPETOR 1 mg/ml, injekcinis tirpalas šunims ir katėms
Active substance:
  • Medetomidine hydrochloride
Target species:
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Medetomidine hydrochloride
    1.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
    • Cat
  • Intravenous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN05CM91
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Available in:
  • Lithuania
Package description:
  • (ID2) 50 millilitre(s): unspecified outer container with 5 Vial each with 10 millilitre(s)
  • (ID1) 10 millilitre(s): unspecified outer container with 1 Vial with 10 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Cp-Pharma Handelsgesellschaft mbH
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/07/1723/001-002
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0116/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • France
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download

RV1723.pdf

Lithuanian (PDF)
Published on: 30/05/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."